Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."

February 20, 2018

US Bioservices now dispenses ERLEADA

The U.S. Food and Drug Administration has approved ERLEADA (apalutamide) for non-metastatic castration-resistant prostate cancer.